Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled Study

Gastroenterology

Volumn 132, Issue 5, 2007, Pages 1746-1756

  Carrión, JosÉ A ^a   Navasa, Miquel ^a   García Retortillo, Montserrat ^a   García Pagan, Juan Carlos ^a   Crespo, Gonzalo ^a   Bruguera, Miquel ^a   Bosch, Jaime ^a   Forns, Xavier ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PEGINTERFERON ALPHA2B; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RIBAVIRIN;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEPATIC VEIN; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK; UNSPECIFIED SIDE EFFECT; VENOUS PRESSURE;

EID: 34247863801     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.03.041     Document Type: Article

References (27)

1. Garcia-Retortillo M., Forns X., Feliu A., Moitinho E., Costa J., Navasa M., Rimola A., and Rodes J. Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology 35 (2002) 680-687
2. Garcia-Retortillo M., Forns X., Llovet J.M., Navasa M., Feliu A., Massaguer A., Bruguera M., Fuster J., Garcia-Valdecasas J.C., and Rimola A. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 40 (2004) 699-707
3. Prieto M., Berenguer M., Rayon J.M., Cordoba J., Arguello L., Carrasco D., Garcia-Herola A., Olaso V., De Juan M., Gobernado M., Mir J., and Berenguer J. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 29 (1999) 250-256
4. Sanchez-Fueyo A., Restrepo J.C., Quinto L., Bruguera M., Grande L., Sanchez-Tapias J.M., Rodes J., and Rimola A. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft. Transplantation 73 (2002) 56-63
5. Forman L.M., Lewis J.D., Berlin J.A., Feldman H.I., and Lucey M.R. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 122 (2002) 889-896
6. Samuel D., Forns X., Berenguer M., Trautwein C., Burroughs A., Rizzetto M., and Trepo C. Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006). J Hepatol 45 (2006) 127-143
7. Firpi R.J., Abdelmalek M.F., Soldevila-Pico C., Reed A., Hemming A., Howard R., Van Der W.W., Lauwers G., Liu C., Crawford J.M., Davis G.L., and Nelson D.R. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C. Liver Transpl 8 (2002) 1000-1006
8. Samuel D., Bizollon T., Feray C., Roche B., Ahmed S.N., Lemonnier C., Cohard M., Reynes M., Chevallier M., Ducerf C., Baulieux J., Geffner M., Albrecht J.K., Bismuth H., and Trepo C. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology 124 (2003) 642-650
9. Shakil A.O., McGuire B., Crippin J.S., Teperman L., Demetris A.J., Conjeevaran H., Gish R., Kwo P., Balan V., Wright T.L., Brass C., and Rakela J. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C. Hepatology 36 (2002) 1253-1258
10. Berenguer M., Palau A., Fernandez A., Benlloch S., Aguilera V., Prieto M., Rayon J.M., and Berenguer J. Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C. Liver Transpl 12 (2006) 1067-1076
11. Dumortier J., Scoazec J.Y., Chevallier P., and Boillot O. Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination. J Hepatol 40 (2004) 669-674
12. Mukherjee S., Rogge J., Weaver L., and Schafer D.F. Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation. Transplant Proc 35 (2003) 3042-3044
13. Alberti A.B., Belli L.S., Airoldi A., de Carlis L., Rondinara G., Minola E., Vangeli M., Cernuschi A., D'Amico M., Forti D., and Pinzello G. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study. Liver Transpl 7 (2001) 870-876
14. Bizollon T., Pradat P., Mabrut J.Y., Chevallier M., Adham M., Radenne S., Souquet J.C., Ducerf C., Baulieux J., Zoulim F., and Trepo C. Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C. Am J Transplant 5 (2005) 1909-1913
15. Bizollon T., Ahmed S.N., Radenne S., Chevallier M., Chevallier P., Parvaz P., Guichard S., Ducerf C., Baulieux J., Zoulim F., and Trepo C. Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence. Gut 52 (2003) 283-287
16. Rodriguez-Luna H., Khatib A., Sharma P., De Petris G., Williams J.W., Ortiz J., Hansen K., Mulligan D., Moss A., Douglas D.D., Balan V., Rakela J., and Vargas H.E. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series. Transplantation 77 (2004) 190-194
17. Blasco A., Forns X., Carrion J.A., Garcia-Pagan J.C., Gilabert R., Rimola A., Miquel R., Bruguera M., Garcia-Valdecasas J.C., Bosch J., and Navasa M. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology 43 (2006) 492-499
18. Boyer T.D. Wedged hepatic vein pressure (WHVP): Ready for prime time. Hepatology 43 (2006) 405-406
19. Scheuer P.J. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13 (1991) 372-374
20. Bosch J., Navasa M., Garcia-Pagan J.C., DeLacy A.M., and Rodes J. Portal hypertension. Med Clin North Am 73 (1989) 931-953
21. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 33 (2000) 846-852
22. Garcia-Retortillo M., and Forns X. Prevention and treatment of hepatitis C virus recurrence after liver transplantation. J Hepatol 41 (2004) 2-10
23. Carrion J.A., Navasa M., Bosch J., Bruguera M., Gilabert R., and Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 12 (2006) 1791-1798
24. Yedibela S., Schuppan D., Muller V., Schellerer V., Tannapfel A., Hohenberger W., and Meyer T. Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation. Liver Int 25 (2005) 717-722
25. Oton E., Barcena R., Moreno-Planas J.M., Cuervas-Mons V., Moreno-Zamora A., Barrios C., Garcia-Garzon S., Moreno A., Boullosa-Grana E., Rubio-Gonzalez E.E., Garcia-Gonzalez M., Blesa C., and Mateos M.L. Hepatitis C recurrence after liver transplantation: viral and histologic response to full-dose PEG-interferon and ribavirin. Am J Transplant 6 (2006) 2348-2355
26. Berenguer M., Prieto M., Rayon J.M., Mora J., Pastor M., Ortiz V., Carrasco D., San Juan F., Burgueno M.D., Mir J., and Berenguer J. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 32 (2000) 852-858
27. Berenguer M., Ferrell L., Watson J., Prieto M., Kim M., Rayon M., Cordoba J., Herola A., Ascher N., Mir J., Berenguer J., and Wright T.L. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 32 (2000) 673-684